Result Summary for SAS10001
| Protocol ID: | SAS10001 |
| Clinical Study ID: | SAS10001 |
| Official Title: | Systemic pharmacodynamic effects of salmeterol, delivered over 3 hours in a cumulative dosing series, from salmeterol/fluticasone propionate/HFA134A metered-dose inhaler (MDI) to total dose 400/2000mcg, in comparison with salmeterol/P 11/12 MDI to total dose 400mcg, and placebo, in a randomised, ... |
| Phase: | Phase 1 |
| Study Indications or Diseases: |
|
| Generic Name: | fluticasone propionate/salmeterol |
| Trade/Product Name: | advair;seretide |
| Approved Drug Label: | http://www.gsk.com/products.html |
| Results Summary: |  Click
here to download result summary. |
| Citations: |
|
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.
